RBC iShares élargit sa gamme de FNB de répartition d’actifs en lançant quatre FNB iShares axés sur le développement durable
TORONTO, 09 sept. 2020 (GLOBE NEWSWIRE) — Aujourd’hui, RBC iShares a élargi sa gamme de fonds négociés en bourse (les […]
TransUnion to Present at Barclays 2020 European Business Services and U.S. Credit Bureau Forum
CHICAGO, Sept. 09, 2020 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) announced that Chris Cartwright, President and CEO, and Todd Cello, […]
Bunker Hill Mining Confirms Numerous High-Grade Silver Exploration Targets Following Digitisation of Historic Data
HIGHLIGHTS A first digitized 3D model of Bunker Hill’s geology has successfully been created with the goal of leveraging the historical […]
NexTech AR Acquires Fast-Growing Profitable Amazon eCommerce Launch Platform
VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]
Immunomedics Announces Key Oral Presentations at ESMO Virtual Congress 2020
Breadth of presentations include i) Full results from ASCENT; ii) Final results from TROPHY U-01 cohort 1; iii) First results […]
Akoustis Announces Two Lecture Presentations at the 2020 IEEE International Ultrasonics Symposium
– IEEE IUS is One of the World’s Pre-eminent Forums for Technical Breakthroughs –– First Lecture Details Company’s 40-Watt Power-Handling, […]
Kymera Therapeutics Appoints Biopharma Veterans Pamela Esposito and Jeff Albers to its Board of Directors
WATERTOWN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and […]
BioXcel Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
NEW HAVEN, Conn., Sept. 09, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical […]
Kaleido Biosciences to Present at Upcoming September Investor Conferences
LEXINGTON, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced that Michael Bonney, Executive Chair, […]
Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A, an Investigational Allogeneic CAR T Therapy for Relapsed/Refractory Multiple Myeloma
DURHAM, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to […]
